Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Subscribe
FREE
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
Subscribe
FREE
Filter Content:
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Video & Webinars
Hematology
3 Jul 2015
SABRINA: Phase 3 study comparing subcutaneous and intravenous rituximab in follicular lymphoma
An update on the safety results of the phase 3 SABRINA study, which is comparing subcutaneous and intravenous rituximab in the maintenance setting of patients with follicular lymphoma.
Hematology
3 Jul 2015
Subgroup analysis of the MCL-002 (SPRINT) trial of lenalidomide in relapsed/refractory MCL
At the 20th Congress of the European Hematology Association (EHA), Marek Trněný, MD, PhD, of Charles University, Prague, Czech Republic, discusses the…
Hematology
3 Jul 2015
Ongoing studies by the German CLL study group (GCLLSG)
At the 20th Congress of the European Hematology Association (EHA), Barbara Eichhorst, MD, of the University of Cologne, Cologne, Germany, discusses…
Hematology
3 Jul 2015
HELIOS: Phase 3 trial of ibrutinib in previously treated CLL/SLL
At the 20th Congress of the European Hematology Association (EHA), Paula Cramer, MD, of the University Hospital Cologne, Cologne, Germany, discusses the…
Cardiology
3 Jul 2015
Animation Demonstrating Implantation of the CARILLON Device
Treatment of Secondary Mitral Regurgitation via Percutaneous Annuloplasty
Cardiology
3 Jul 2015
Video of Patient Case Showing Real-Time Implantation of the CARILLON Device
Treatment of Secondary Mitral Regurgitation via Percutaneous Annuloplasty: Video of Patient Case Showing Real-Time Implantation of the CARILLON Device.
Hematology
26 Jun 2015
ENDEAVOR: A phase 3 study of carfilzomib in relapsed myeloma
At the 20th Congress of the European Hematology Association (EHA), Jesús F. San Miguel, MD, of the Clínica Universidad de Navarra, Navarra, Spain…
Hematology
26 Jun 2015
Results of the phase 4 EXELS study of high-risk patients with essential thrombocythemia
At the 20th Congress of the European Hematology Association (EHA), Claire Harrison, MD, DM, FRCP, FRCPath, of Guy’s and St Thomas’ NHS Foundation Trust…
Loading posts...
« Previous
1
…
92
93
94
95
96
…
104
Next »